{"name":"Angiogenix","slug":"angiogenix","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE95cVdLdS10RzE0Y3BKTHlPdWNWb1ZZZmRTVExTR3pCZ3NieFZQdXREQ19ZTEk1ZUxJVFJKYVl1bFY5V2ZEX2lZRFlyZHc3eFJ5Q19YOFNWVWt6N3lDN0Nj?oc=5","date":"2025-12-08","type":"pipeline","source":"Nature","summary":"Pharmacological activation of p53 induces dose-dependent changes in endothelial cell fate during angiogenic sprouting | Cell Death & Disease - Nature","headline":"Pharmacological activation of p53 induces dose-dependent changes in endothelial cell fate during angiogenic sprouting | ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE56c2x4YjFUM29IMGJ3cDY4LUY4MkEtRGl4WlBRaGdsVWpQQkdpd29la2NldWd2SnA2UVZXUE9tQkVhQmlhLS1OTzBrRFFUTkx2Q0lkNjhlckROMlVrcHo0?oc=5","date":"2025-05-23","type":"pipeline","source":"Nature","summary":"PRL3-zumab as an anti-angiogenic therapy in neovascular eye diseases - Nature","headline":"PRL3-zumab as an anti-angiogenic therapy in neovascular eye diseases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE5wU25GOW8xZ2JsYU5SOHk5UUFiaE4xenIybnlPQ3paanA2MTJFY0Q2Tm9uQ29EOEQ3M3YzSWR4QkdOd213RXhkYU1xcjFnS2xMZ1hEMkJlZVBzOWd3dThGbU5weVdDVDY1MW5R?oc=5","date":"2024-10-23","type":"pipeline","source":"Wiley Online Library","summary":"New Anti‐Angiogenic Therapy for Glioblastoma With the Anti‐Depressant Sertraline - Tsuboi - 2024 - Cancer Medicine - Wiley Online Library","headline":"New Anti‐Angiogenic Therapy for Glioblastoma With the Anti‐Depressant Sertraline - Tsuboi - 2024 - Cancer Medicine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE83VHpKUFZJRmplTGNkRVBwRlZtVkQ4bU1veXJtVXZIQ3RIRHVxbjU4OUs1RU16Z28xN2xkVnBYT3dqc0JIeUxOamNrakZ0RkdDem1nUlZHRjBDNU5naWJoYlRLZFN1b1B5LUJqUkVtc19LSDR0aGRoOTNZNUY?oc=5","date":"2024-05-02","type":"trial","source":"American Heart Association Journals","summary":"Angiogenic Gene Therapy for Refractory Angina: Results of the EXACT Phase 2 Trial - American Heart Association Journals","headline":"Angiogenic Gene Therapy for Refractory Angina: Results of the EXACT Phase 2 Trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE9EUXAxZkE5bjYyejAzUVRIUmRlSEg1Q3NuNWVRd1lPTWhGVTJ3WDVHOTVrVE5waEJYRjZpQjFibUxhR0JUbmVhYmZSWUtoYUprTVhYbHRaaWljX1lqV2M4NHVyYVRjdzN5RWdoZ2N6aw?oc=5","date":"2024-01-01","type":"pipeline","source":"Wiley Online Library","summary":"Anti-angiogenic therapy enhances cancer immunotherapy: Mechanism and clinical application - Wiley Online Library","headline":"Anti-angiogenic therapy enhances cancer immunotherapy: Mechanism and clinical application","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE5iV3YzT1UtYjlFWWNPMHFhdXpQRllCSTIwZVNsWUR4UXpPcXkwdGM5WThmYnZNblFfbzZZTDVNN2ozUFBpSEEyX0hnQlFYQy03YlN4QWJyNTFYNkRZeHE3TTNkbTl5RUd6b2diSlhqd213Mmc3MXc?oc=5","date":"2023-09-14","type":"pipeline","source":"Wiley","summary":"Red Light-Triggered Anti-Angiogenic and Photodynamic Combination Therapy of Age-Related Macular Degeneration - Wiley","headline":"Red Light-Triggered Anti-Angiogenic and Photodynamic Combination Therapy of Age-Related Macular Degeneration","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5TcnhXZG1XN21Md3ZnZWFwQ2dVNE9HeFZSaFpJX0FNQ0NDU19JNUZLYU1BVmkzbFhJS2UwclNNRnU1eWJhaG5ob3N2YUx5dFNIT1JyVWNVN19haWlqVGs0?oc=5","date":"2023-05-11","type":"pipeline","source":"Nature","summary":"Angiogenic signaling pathways and anti-angiogenic therapy for cancer - Nature","headline":"Angiogenic signaling pathways and anti-angiogenic therapy for cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE9jZTNaODhnVTJUTHJDZWJyUFdiRVpVWjloN0hqS3ZoNm1TNE5ldUYtZ1FiN0pUTnQwelMzdFFaSkY1ak5nQmpOSHR3OEFERXV1NHF5aGdFUWVOblphQUkyaEhlcjFfNi01U0tsb3BQdw?oc=5","date":"2022-05-11","type":"pipeline","source":"Wiley","summary":"CXCL10 is a novel anti‐angiogenic factor downstream of p53 in cardiomyocytes - Wiley","headline":"CXCL10 is a novel anti‐angiogenic factor downstream of p53 in cardiomyocytes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxQRlJtb3MybXdDZmZWajJCTGdQSnFLampWeFZYSnRJUXlpVFVaYTRXdHllZTd5eENDQ3lXVmNRVlRKSk96ZTgtNkdlY1ZQWDdNYS1vUUVOM29jaE1EeGVzdFRxR3kyaFAzLW13c2I0bXEzeDJvcVp2U0NMQklmOFpCNg?oc=5","date":"2019-10-01","type":"pipeline","source":"retailpharmacymagazine.com.au","summary":"New PBS listing to treat lung cancer - retailpharmacymagazine.com.au","headline":"New PBS listing to treat lung cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE4xX2ZJZldrcFNqaFF2cU00S2d6UHNhX2ZXWEM0eWxHRENaWXZvTklNYXVpbW9UTUFqVVZaTExnY3JQYjduV0RIVHhveUtXb1VNUnlQQUpYOF9rdWtqcXpkVlkxRnpqWEx0T0xZY2ZyNVBSSXRPd2hlajlhOA?oc=5","date":"2018-04-30","type":"pipeline","source":"ScienceDirect.com","summary":"Omega-3 polyunsaturated fatty acids promote angiogenesis in placenta derived mesenchymal stromal cells - ScienceDirect.com","headline":"Omega-3 polyunsaturated fatty acids promote angiogenesis in placenta derived mesenchymal stromal cells","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}